Approval · Notice of Compliance 20127 · 2017
BENLYSTA: Notice of Compliance 20127
Issued December 7, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20127
- Date
- December 7, 2017
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New formulation and route of administration
Products in this notice
Medicinal ingredients
- BELIMUMAB 200 MG per SYR